Laryngeal Mask Airway as a Bridge for Intubation of Obese Patients for Sleeve Gastrectomy

May 6, 2020 updated by: Abdelrhman Alshawadfy, Suez Canal University

Assessment of the Use of Laryngeal Mask Airway as Abridge for Intubation of Morbidly Obese Patients Undergoing Sleeve Gastrectomy

Ventilation, as well as intubation of a morbidly obese patient, is challenging and require special preparations and skilful hands, in this study laryngeal mask airway insertion is used as a bridge for intubation to facilitate ventilation as give enough time to anaesthetics and muscle relaxants to work on.

Study Overview

Status

Completed

Detailed Description

The ordinary pathway of intubating a morbidly obese patient for sleeve gastrectomy is bordered by the risk of difficult ventilation and intubation with the subsequent events of hypoxia and hypoventilation. When the patient is easy ventilated, it gives some sort of confidence and pleasure for the anaesthetist that the way of intubation will not be so hard.

One problem here is the difficulty of ventilating a morbidly obese patient, in this study the investigators used laryngeal mask airway as a bridge before inserting the endotracheal tube

Study Type

Interventional

Enrollment (Actual)

36

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Ismailia, Egypt
        • Suez Canal University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 50 years (ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Morbid obese patient BMI>40
  • ASA I, II, III
  • Elective sleeve gastrectomy

Exclusion Criteria:

  • Oral cavity infection or pathological abnormalities
  • Suspected or known abnormalities in supraglottic anatomy
  • Patients planned for awake fiberoptic intubation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: PREVENTION
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
ACTIVE_COMPARATOR: Face mask ventilation
Use of face mask ventilation technique after induction of anaesthesia and administration pf muscle relaxant till the insertion of the endotracheal tube in a morbidly obese patient undergoing sleeve gastrectomy
use of face mask before intubation of a morbidly obese patient
ACTIVE_COMPARATOR: Laryngeal mask ventilation
Use of laryngeal mask airway LMA for ventilation after induction of anaesthesia and administration pf muscle relaxant till the insertion of the endotracheal tube in a morbidly obese patient undergoing sleeve gastrectomy
Insertion of laryngeal mask airway before intubation of a morbidly obese patient
Other Names:
  • LMA

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Time to intubation TTI
Time Frame: During the action of intubation after induction of anaesthesia
The time starts with insertion of glidescop and ends at its withdrawal
During the action of intubation after induction of anaesthesia

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
View of the glottis
Time Frame: During the action of intubation after induction of anaesthesia
Based on the percentage of glottic opening (POGO) score as well as Cormack and Lehane's (C&L) classification
During the action of intubation after induction of anaesthesia
Number of attempts required for intubation,
Time Frame: During the action of intubation after induction of anaesthesia
How many times the anaesthetist needs to try to succeed in insertion of the endotracheal tube
During the action of intubation after induction of anaesthesia
Anaesthetist's satisfaction score
Time Frame: During the action of intubation after induction of anaesthesia
On a scale rang from 0 representing totally dissatisfied to 10 representing fully satisfied
During the action of intubation after induction of anaesthesia
Intubation difficulty score (IDS)
Time Frame: During the action of intubation after induction of anaesthesia
Intubation difficulty score (IDS) is the sum of seven variables, each presents 1 point, score 0 represents easy intubation, score 1 to 5 represents moderate difficulty and score more than 5 was considered difficult intubation.
During the action of intubation after induction of anaesthesia
Need for external pressure during intubation
Time Frame: During the action of intubation after induction of anaesthesia
to direct the larynx downward to facilitate endotracheal intubation
During the action of intubation after induction of anaesthesia

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

February 1, 2019

Primary Completion (ACTUAL)

August 30, 2019

Study Completion (ACTUAL)

January 30, 2020

Study Registration Dates

First Submitted

May 4, 2020

First Submitted That Met QC Criteria

May 6, 2020

First Posted (ACTUAL)

May 7, 2020

Study Record Updates

Last Update Posted (ACTUAL)

May 8, 2020

Last Update Submitted That Met QC Criteria

May 6, 2020

Last Verified

May 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • LMA obesity

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Bariatric Surgery Candidate

Clinical Trials on face mask

3
Subscribe